General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Illouz F et al. - Tyrosine kinase inhibitors (TKI) belong to new molecular multitargeted therapies which are approved for the treatment of hematologic and solid tumors. They interact with a large variety of protein tyrosine kinases involved in oncogenesis.

Related Articles

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Modern Pathology, 10/28/09    Relevance Score: 93%

Subcellular Localization of the HER4 Intracellular Domain, 4ICD, Identifies Distinct Prognostic Outcomes for Breast Cancer Patients
American Journal of Pathology, 10/06/09    Relevance Score: 93%

When should we be conducting thyroid function tests in newborns and young infants
BMJ - Archives of Diseases in Childhood, 10/26/09    Relevance Score: 89%

Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
Rheumatology, 10/08/09    Relevance Score: 89%

Evaluation of thyroid status of infants in the intensive care setting
Singapore Medical Journal, 10/05/09    Relevance Score: 89%

Today in Endocrine...keeping you current

Levels of oxidative damage and lipid peroxidation in thyroid neoplasia
Head & Neck, 12/10/09

Parathyroidectomy in the elderly population: Does age really matter
The Laryngoscope, 12/08/09

Superficial selective cervical plexus block following total thyroidectomy: A randomized trial
Head & Neck, 12/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address